Recent studies have shown that oxidative stress generated by hyperglycemia is one of the major mediators of cardiac hypertrophy and dysfunction in diabetic cardiomyopathy, so NF-κB may function as a necessary mediator of the cardiac response in the pathogenesis of diabetic cardiomyopathy. Here, NFKB1 is linked to diabetic cardiomyopathy.